EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Translational Barriers to AAV and CRISPR Gene Therapy in Diabetes

Abdulrahman G Alharbi iD

Saudi Medical Journal · 20.03.2026 · 47 (4) · 626-652

DOI: 10.15537/1658-3175.1061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Saudi Medical Journal, online erschienen am 20.03.2026. Verfasst von Abdulrahman G Alharbi. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al Medina Al Munawara, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Genetic Therapy, Diabetes Mellitus, Dependovirus, Translational Research, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene therapy targets diabetes pathophysiology rather than symptoms, yet clinical translation is slower than preclinical success. This review synthesizes 143 registered trials (ClinicalTrials.gov, 2010-2025) identifying systematic implementation barriers. Despite >15 years of development, 83% of trials remain in Phase I-II. Only zimislecel achieved Phase III outcomes (83% insulin independence at 12 months, n=12, requiring immunosuppression). VM202 for diabetic neuropathy failed Phase III despite positive extension results. Three systematic barriers emerged: (1) human transduction efficiency is 6-8.7-fold lower than preclinical models; (2) pre-existing immunity excludes 58-78% of candidates; (3) manufacturing capacity serves

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyDiabetes MellitusDependovirusTranslational Research, BiomedicalCRISPR-Cas SystemsHumansAnimalsGene Transfer TechniquesClinical Trials as TopicGenetic Vectors

Stichwörter der Autor:innen

CRISPR-Cas9Clinical trialsDiabetes mellitusGene therapyImmune modulationInsulin gene deliveryViral vectorsβ-cell regeneration

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al Medina Al Munawara, Kingdom of Saudi Arabia.

ORCID-Profile: Abdulrahman G Alharbi

Zitieren

APA

Alharbi, A. G. (2026). Translational Barriers to AAV and CRISPR Gene Therapy in Diabetes. Saudi Medical Journal, 47(4), 626-652. https://doi.org/10.15537/1658-3175.1061

Vancouver

Alharbi AG. Translational Barriers to AAV and CRISPR Gene Therapy in Diabetes. Saudi Medical Journal. 2026;47(4):626-652. doi:10.15537/1658-3175.1061

BibTeX
@article{Alharbi2026,
  author = {Alharbi, Abdulrahman G},
  title = {Translational Barriers to AAV and CRISPR Gene Therapy in Diabetes},
  journal = {Saudi Medical Journal},
  year = {2026},
  volume = {47},
  number = {4},
  pages = {626--652},
  doi = {10.15537/1658-3175.1061}
}
Kostenlos starten →